Exclusive

Publication

Byline

Location

US Patent Issued to PERSEUS PROTEOMICS on Oct. 6 for "Composition containing buffer" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,008, issued on Oct. 6, was assigned to PERSEUS PROTEOMICS INC. (Tokyo). "Composition containing buffer" was invented by Yuichi Funase (Ashig... Read More


US Patent Issued to The Regents of the University of California, Triad National Security, The Arizona Board of Regents on Oct. 6 for "Ionic liquids for transdermal drug delivery" (California, New Mexico, Utah, Arizona, Maryland, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,009, issued on Oct. 6, was assigned to The Regents of the University of California (Oakland, Calif.), Triad National Security LLC (Los Alamos... Read More


US Patent Issued to SAMYANG HOLDINGS on Oct. 6 for "Pharmaceutical composition containing anionic drug, and preparation method therefor" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,010, issued on Oct. 6, was assigned to SAMYANG HOLDINGS Corp. (Seoul, South Korea). "Pharmaceutical composition containing anionic drug, and... Read More


US Patent Issued to SHANGHAI JEYOU PHARMACEUTICAL, JIANGXI JEMINCARE GROUP on Oct. 6 for "Benzoheterocycle substituted tetrahydroisoquinoline compound" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,011, issued on Oct. 6, was assigned to SHANGHAI JEYOU PHARMACEUTICAL Co. LTD (Shanghai) and JIANGXI JEMINCARE GROUP Co. LTD (Nanchang, China)... Read More


US Patent Issued to BeOne Medicines | on Oct. 6 for "EGFR degraders and associated methods of use" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,012, issued on Oct. 6, was assigned to BeOne Medicines | GmbH (Basel, Switzerland). "EGFR degraders and associated methods of use" was inven... Read More


US Patent Issued to Dyne Therapeutics on Oct. 6 for "Muscle targeting complexes and formulations for treating facioscapulohumeral muscular dystrophy" (German, American Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,013, issued on Oct. 6, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.). "Muscle targeting complexes and formulations for treating fa... Read More


US Patent Issued to The Scripps Research Institute on Oct. 6 for "Disruption of CD28-sialoside ligand complexes to enhance T cell activation" (California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,014, issued on Oct. 6, was assigned to The Scripps Research Institute (La Jolla, Calif.). "Disruption of CD28-sialoside ligand complexes to ... Read More


US Patent Issued to SUNMED THERAPEUTIC on Oct. 6 for "Anti-galectin 3 antibodies and their use in epilepsy and related diseases" (Chinese Inventor)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,015, issued on Oct. 6, was assigned to SUNMED THERAPEUTIC Ltd. (Hong Kong). "Anti-galectin 3 antibodies and their use in epilepsy and relate... Read More


US Patent Issued to NEXTAGE THERAPEUTICS on Oct. 6 for "Drug containing targeting liposomes" (Israeli Inventor)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,016, issued on Oct. 6, was assigned to NEXTAGE THERAPEUTICS LTD. (Nes Ziona, Israel). "Drug containing targeting liposomes" was invented by ... Read More


US Patent Issued to The Texas A&M University System, William Marsh Rice University, The Trustees of Indiana University on Oct. 6 for "Therapeutic carbon nanomaterial H 2 S oxidants for biological polysulfide synthesis" (Texas, Michigan, California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,017, issued on Oct. 6, was assigned to The Texas A&M University System, William Marsh Rice University and The Trustees of Indiana University.... Read More